Under construction – not a live service
Sign in
Taking people in United StatesNo phase

Longitudinal Autonomic Characterization as a Predictor for Secondary Medical Complications Post-SCI

Key facts

Where
Rochester, United StatesSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 75 years old?

Source: NCT07210437, who can take part

Where in United States

  • Mayo ClinicRochester, United StatesContact: Erin LundTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Trial details

Who runs it
Mayo Clinic
Trial code
NCT07210437
Record updated
28 May 2026
Original description
The purpose of this research is to learn about how the body is able to balance changes in blood pressure, how that changes over time, and how these changes impact a participant's risk of developing medical problems.Read full original descriptionShow less

The purpose of this research is to learn about how the body is able to balance changes in blood pressure, how that changes over time, and how these changes impact a participant's risk of developing medical problems.

Inclusion: 18-75 years old; Spinal cord injury with neurological level of injury from C6-T12; ASIA Impairment Scale A-D; Either acute SCI <3 months prior (n=10) or chronic SCI (>1 year since injury, n=8).

Exclusion: Taking or being administered a medication known to potentially have adverse interactions with phenylephrine; Symptoms of cardiovascular (including, but not limited to: hypertension, stroke, chest pain, etc.), respiratory, peripheral neurological or autonomic disease (particularly diabetes mellitus requiring treatment); In the judgement of the principal investigator, any illness or condition that will interfere with the patient's ability to comply with the protocol, compromise patient safety, or interfere with the interpretation of the study results; Women who are pregnant or lactating.

ClinicalTrials.gov NCT07210437